NEONC TECHNOLOGIES HOLDINGS, INC. Interest Expense
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Interest Expense of $234.37 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. interest expense for the quarter ending 2026-06-30 was $234.37K, a 380.76% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest expense for the quarter ending 2026-03-31 was $982.62K, a 218.08% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest expense for the quarter ending 2025-12-31 was $1.28M.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest expense for the quarter ending 2025-09-30 was $869.82K.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest expense for fiscal 2025 was $2.50M, a 2.05% decline from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. interest expense for fiscal 2024 was $2.56M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $234.37K 10-Q · filed 2026-08-10 | $1.22M 10-Q · filed 2026-08-10 | $2.49M derived: sum of 3 quarters · filed 2026-08-10 | $3.36M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $982.62K 10-Q · filed 2026-05-15 | $2.26M derived: sum of 2 quarters · filed 2026-05-15 | $3.13M derived: sum of 3 quarters · filed 2026-05-15 | $3.18M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.15M derived: sum of 2 quarters · filed 2026-03-31 | $2.20M derived: sum of 3 quarters · filed 2026-08-10 | $2.50M 10-K · filed 2026-03-31 |
| 2025-09-30 | $869.82K 10-Q · filed 2025-11-14 | $918.57K derived: sum of 2 quarters · filed 2026-08-10 | $1.23M 10-Q · filed 2025-11-14 | $1.23M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $48.75K 10-Q · filed 2026-08-10 | $357.67K 10-Q · filed 2026-08-10 | $355.27K derived: sum of 3 quarters · filed 2026-08-10 | $355.27K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $308.92K 10-Q · filed 2026-05-15 | $306.52K derived: sum of 2 quarters · filed 2026-05-15 | $306.52K derived: sum of 3 quarters · filed 2026-05-15 | $1.48M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$2.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$2.40K derived: sum of 2 quarters · filed 2026-03-31 | $1.17M derived: sum of 3 quarters · filed 2026-03-31 | $2.56M 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.17M derived: sum of 2 quarters · filed 2025-11-14 | $2.56M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $1.17M 10-Q · filed 2025-08-18 | $2.56M 10-Q · filed 2025-08-18 | ||
| 2024-03-31 | $1.39M 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |